"Jefferies also reiterated a "Buy" on NVDA. The firm noted, "One of the clear takeaways from the conference is that the entire ecosystem is chasing NVDA. We are seeing everyone chasing the scale-up opportunity at a multiyear disadvantage vs NVDA," as quoted by CNBC. Analysts at Barclays just raised their price target on Taiwan Semiconductor to $275 with an "Overweight" rating. That was after TSM raised its 2025 revenue guidance to mid-30% growth and reiterated plans to invest $42 billion in capital expenditures by year's end. Taiwan Semiconductor also posted a 39.1% jump in third-quarter profits."
""In a note to clients published Thursday titled 'AI Spending Is Not Too Big,' Goldman Sachs economist Joseph Briggs made the case that the billions being spent on building out data centers - known as capital expenditures, or 'capex' - remains sustainable.""
"Analysts at Bank of America just reiterated a "Buy" rating on NVIDIA (NASDAQ: NVDA). The firm says NVDA is well-positioned for healthcare and artificial intelligence. "Nvidia, a leader in accelerated computing, has broadened its reach into high-compute healthcare workloads and continues to engage in partnerships on the application side," they said, as quoted by CNBC."
Markets are attempting to shrug off trade tensions, a federal government shutdown and regional bank disclosures about bad and fraudulent loans. Some economists express concern about a potential AI bubble, while others view AI spending and data-center capital expenditures as sustainable. Major technology and semiconductor companies are receiving reiterated Buy ratings and higher price targets. NVIDIA is positioned for healthcare and AI workloads, and its ecosystem advantage is widely noted. Taiwan Semiconductor raised 2025 revenue guidance, plans $42 billion in capex and reported a 39.1% jump in third-quarter profits. AMD carries a $300 price target and targets large addressable markets in PC, server, gaming and deep learning.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]